-
In this issue: Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions.
-
-
The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure is currently updating its work in JNC-7 in an effort to help physicians provide safe, effective, and patient-centered care for those with elevated blood pressure.
-
A patient tells you she heard a news story that said that oral contraceptives (OCs) have lasting effect on hormone levels, dulling a womans sexual desire. What is your response?
-
The woman sitting in front of you says for about 10 days of every month, she experiences depression, marked anxiety, sudden mood shifts, persistent irritability, and bloating.
-
New information from two case control studies of the transdermal contraceptive (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) indicates no increased risk of heart attack or stroke for women who choose the patch, but data conflict on the occurrence of venous thromboembolism (VTE).
-
Circle May 26-June 1 for the 51st annual meeting of the American College of Nurse-Midwives (ACNM) Annual Meeting in Salt Lake City. Sessions will include a primary care update, a workshop on endometrial biopsy indications and techniques, and information on advanced billing and coding.
-
New figures from the Centers for Disease Control and Prevention (CDC) show that despite an approximate 5% annual decline in the 2001-2004 rate of diagnoses among African Americans, the epidemic continues to make a severe impact on that ethnic group.
-
This promises to be a rocky year for federal family planning policy with potentially serious implications for the millions of low-income women who rely on Medicaid, Title X of the Public Health Service Act, and other federal programs for their family planning care.
-
You deliver some bad news to your next patient, a 16-year-old student: She has a chlamydia infection. She then asks, What is chlamydia?